Navigation Links
National Parkinson Foundation Awards $3.7 Million in Grants
Date:8/5/2008

MIAMI, Aug. 5 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) announced it will fund $3.7 million in grant programs dedicated to Parkinson's disease research, care and outreach worldwide. Grants were awarded to institutions in the Foundation's network of 44 centers of excellence, 10 comprehensive care centers, and 10 outreach centers. Through centers alone, NPF reaches more than 50,000 patients with Parkinson's disease and almost 70,000 patients with movement disorders.

"This year we received novel projects from a record number of centers and investigators worldwide," said Michael S. Okun, MD, National Medical Director of NPF. "The NPF funding continues to catalyze important discoveries and advances that make a difference for patients and families suffering today with this disease. As a result, dollars donated to NPF have an immediate and measurable impact."

Centers Grants

NPF dedicated approximately $1 million (24 percent) to research, more than $640,000 (19 percent) to comprehensive care, and more than $1.5 million (57 percent) to outreach for the 2008-2009 fiscal year.

Research funded is largely clinical and included studies of genetics, potential treatment, cognition and depression, and fall prevention. Programs funded in comprehensive care were diverse and included grants focusing on advanced-stage Parkinson's disease and continuity of care. Of the 36 outreach grants, 28 sought to reach underserved and culturally diverse populations.

This program was supported, in part, by generous grants from the Parkinson's Unity Walk and The Parkinson Alliance.

Small Research Grants

NPF awarded seven grants totaling $350,000 for studies piloting novel research ideas.

Researchers who received grants include:

-- Stephen Traynelis, PhD, Emory University;

-- Eugene Mosharov, PhD, Columbia University;

-- Esti Yeger-Lotem, PhD, Whitehead Institute for Biomedical Research, MIT;

-- Yvonne Schmitz, PhD, Columbia University;

-- Christophe Lo Bianco, PhD, Wallenburg Neuroscience Center at Lund University;

-- Andrea Giuffrida, PhD, University of Texas Health Science Center; and

-- Claudio Hetz, PhD, University of Chile.

About The National Parkinson Foundation

Founded in 1957 and headquartered in Miami, the National Parkinson Foundation is the oldest Parkinson's organization, with the most extensive grassroots network of centers, chapters and support groups in the U.S., Canada, and internationally. Since 1984, NPF has invested over $130 million in disease-related programs and is committed to increasing the quality of care for Parkinson's patients through research, education, care support and outreach services. For more information about NPF and allocation of grants please visit http://www.parkinson.org or call 800-327-4545.

CONTACT: Jamie Schwartzberg of National Parkinson Foundation,

+1-305-243-8165, jschwartzberg@parkinson.org


'/>"/>
SOURCE National Parkinson Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Ten outstanding teachers in the Greater Houston area ... will win a visit by a Houston Texans player, two tickets to a Texans ... years old can visit texanschecking.com/stars to nominate their favorite teacher with an essay of ...
(Date:8/16/2017)... Georgia (PRWEB) , ... August 16, 2017 , ... ... in Atlanta, opened their doors. They celebrate 30 years in business this year, ... create an up-to-date, inviting, tranquil space to serve their patients. , It ...
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced ... draws. By broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization ... out of a needle stick and more importantly, helps our staff members locate a ...
(Date:8/16/2017)... ... 2017 , ... A global leader in the treatment of clubfoot, CURE ... Indian states—bringing the country one step closer to eliminating clubfoot as a lifelong disability ... on track to enroll 10,000 children in the clubfoot treatment program in this year ...
(Date:8/16/2017)... ... ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has announced their ... a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their content will ... in 2018. Proceeds will be going to further health research. , Fusion Flix ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... -- Axium Pharmaceuticals Inc., the creator of the drug Truveta for ... of an IPO. The United States ... of a prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... staggering figure is the fact that Americans spent $42 billion on anxiety ...
(Date:8/14/2017)... Israel , Aug. 15, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced financial ... "We are in ... 3 trial to investigate NurOwn ® in ALS," ... Officer of BrainStorm. "We have agreements with Mass. General ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: